Generic Name Methylprednisolone Peak Unknown

Clinical Medications Worksheets Trade Name Classification Dose Route Solu-medrol Corticosteroids 40 mg IVP Onset Duration Normal dosage range 40-250 mg q 4-6 hr. rapid unknown

Time/frequency BID

Why is your patient getting this medication

Suppression of inflammation and modification of the normal immune response

For IV meds, compatibility with IV drips and/or solutions

Rate: Low dose (< 1.8 mg/kg or < 125 mg/dose): May be administered direct IV push over 1 to several minute

Mechanism of action and indications (Why med ordered)

agents suppress inflammation and the normal immune response

Nursing Implications (what to focus on) Contraindications/warnings/interactions Active untreated infections. Caution with long term use Common side effects Depression, euphoria, hypertension, anorexia, nausea, acne, decreased wound healing, ecchymoses, fragility, hirsutism, petechiae, adrenal suppression, muscle wasting, osteoporosis, long term use may cause moon face and buffalo hump. Lab value alterations caused by medicine
Monitor serum electrolytes and glucose. May cause hyperglycemia, especially in persons with diabetes. May cause hypokalemia. Patients on prolonged therapy should routinely have hematologic values, serum electrolytes, and serum and urine glucose evaluated. May WBCs. May cause hyperglycemia, especially in persons with diabetes. May serum potassium and calcium and serum sodium concentrations

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) May effects of insulin, may decrease salicylate and isoniazid levels and effectiveness.

Be sure to teach the patient the following about this medication

Corticosteroids cause immunosuppression and may mask symptoms of infection. Instruct patient to avoid people with known contagious illnesses and to report possible infections immediately. Patient should also report unusual swelling, weight gain, tiredness, bone pain, bruising, nonhealing sores, visual disturbances, or behavior changes. carry identification describing disease process and medication regimen in the event of emergency in which patient cannot relate medical history

Nursing Process- Assessment (Pre-administration assessment)

Monitor intake and output ratios and daily weights. Observe patient for peripheral edema, steady weight gain, rales/crackles, or dyspnea. Notify physician or other health care professional if these occur

Assessment Why would you hold or not give this med?

Assess patient for signs of adrenal insufficiency (hypotension, weight loss, weakness, nausea, vomiting, anorexia, lethargy, confusion, restlessness) before and periodically during therapy

Evaluation Check after giving

Decrease in presenting symptoms with minimal systemic side effects